Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease.

ABSTRACT:

Background

Medicinal cannabis (MC) is being used for symptomatic relief by many patients with inflammatory bowel disease (IBD), often independently of clinical guidance. Such use presents challenges for supporting clinicians. The aim of this study was to determine the current attitudes, knowledge, and experience of gastroenterologists toward patient use of MC for symptom management in IBD.

Methods

Australian gastroenterologists (n = 70) and trainees (n = 23) completed an anonymous, 30-item questionnaire, probing their knowledge, attitudes, and experience with MC in managing IBD. Survey data were collected between April and August 2019.

Results

Thirty-nine percent of survey respondents reported having patients using MC; however, only a minority supported

SUBMITTER: Benson MJ 

PROVIDER: S-EPMC9802365 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature